Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact
Richard Drexler(Universität Hamburg), Malte Mohme(Universität Hamburg), Helena Bode(Universität Hamburg), Florian Brembach(Universität Hamburg), Manfred Westphal(Universität Hamburg), Ulrich Schüller(Universität Hamburg), Franz Ricklefs(Universität Hamburg), Jens Gempt(Universität Hamburg), Alicia Eckhardt(Universität Hamburg), Jennifer Sauvigny(Universität Hamburg), Katrin Lamszus(Universität Hamburg)
Cited by 27
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma
|Journal of Clinical Oncology|2013|488
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
|The Lancet Oncology|2013|404
A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth <i>In vivo</i>
|Clinical Cancer Research|2006|303
The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2
|Stem Cell Reports|2022|239